Agosto 2019 vol. 6 num. 1 - IV Encontro Nacional de Economia Industrial e Inovação

Artigo completo - Open Access.

Idioma principal

Interaction between Big-Pharma’s and Small Enterprises: an Analyses Focused on the Incorporation of Inventors

Matos, Murilo Montanari de ;

Artigo completo:

O artigo foca na incorporação de conhecimento pela grande empresa farmacêutica em processos de aquisição de pequenas empresas. O objetivo é identificar em que grau a incorporação do conhecimento relacionado aos inventores é efetivada nesse processo. Usa-se uma metodologia qualitativa, que parte de uma amostra de grandes empresas farmacêuticas e as pequenas empresas adquiridas por elas no período de 2005 a 2012. A partir da amostra compilou-se as patentes concedidas às pequenas empresas junto ao USPTO, por meio da base PatFT. A análise desenvolve duas medidas centrais. A primeira é o uso de inventores definida como os inventores das pequenas que ao serem incorporados passam a patentear pela grande empresa. A outra é a incorporação de trajetórias de pesquisa entendido como os inventores que citam seu trabalho passado à medida que são incorporados à grande empresa. Conclui-se que as grandes empresas incorporam inventores de pelo menos uma das empresas adquiridas, porém o número de inventores incorporados é relativamente baixo. Mais rara é a incorporação de trajetórias de pesquisa que, por isso, demonstram sua relevância.

Artigo completo:

Download (PDF)

Palavras-chave: Aquisição, Indústria Farmacêutica, Pequenas Empresas, Patentes,

Palavras-chave:

DOI: 10.5151/iv-enei-2019-3.3-091

Referências bibliográficas
  • [1] ACHILLADELIS, B.; ANTONAKIS, N. The dynamics of technological innovation: the case of the pharmaceutical industry. In: Research Policy, n. 30, pp 535-588, 2001
  • [2] AHUJA, G.; KATILA, R. Technological Acquisition and the Innovation Performance of Acquiring Firms: A Longitudinal Study. Strategic Management Journal, v. 22, n. 3, p. 197–220, 2001.
  • [3] ALMEIDA, P.; HOHBERGER, J.; PARADA, P. Individual scientific collaborations and firm-level innovation. Industrial and Corporate Change, v. 20, n. 6, p. 1571–1599, 2011.
  • [4] ANDERSSON, M.; XIAO, J. Acquisitions of start-ups by incumbent businesses: A market selection process of “high-quality” entrants? Research Policy, v. 45, n. 1, p. 272–290, 2016.
  • [5] BAUMOL, W. J. Entrepreneurship, Innovation and Growth: The David-Goliath Symbiosis. The Journal of Entreprenurial Finance, v. 7, n. 2, p. 1–11, 2002.
  • [6] BLOMKVIST, K.; KAPPEN, P.; ZANDER, I. Superstar inventors - Towards a people-centric perspective on the geography of technological renewal in the multinational corporation. Research Policy, v. 43, n. 4, p. 669–682, 2014.
  • [7] CASSIMAN, B.; VEUGELERS, R. Are external technology sourcing strategies substitutes or complements: The case of embodied versus disembodied technology acquisition. v. 3, n. 672, p. 1–22, 200
  • [8] CLOODT, M.; HAGEDOORN, J.; VAN KRANENBURG, H. Mergers and acquisitions: Their effect on the innovative performance of companies in high-tech industries. Research Policy, v. 35, n. 5, p. 642–654, 2006.
  • [9] COLOMBO, M. G.; PIVA, E. Firms’ genetic characteristics and competence-enlarging strategies: A comparison between academic and non-academic high-tech start-ups. Research Policy, v. 41, n. 1, p. 79–92, 2012.
  • [10] DESYLLAS, P.; HUGHES, A. Sourcing technological knowledge through corporate acquisition: Evidence from an international sample of high technology firms. Journal of High Technology Management Research, v. 18, n. 2, p. 157–172, 2007.
  • [11] DESYLLAS, P.; HUGHES, A. Do high technology acquirers become more innovative? Research Policy, v. 39, n. 8, p. 1105–1121, 2010.
  • [12] GASSMANN, O.; REEPMEYER, G. Organizing pharmaceutical innovation: From science-based knowledge creators to drug-oriented knowledge brokers. Creativity and Innovation Management, v. 14, n. 3, p. 233–245, 2005.
  • [13] GRANSTRAND, O. et al. External technology acquisition in large multi-technology corporations. R&D Management, v. 22, n. 2, p. 111–134, 1992.
  • [14] GRANSTRAND, O. Corporate Innovation Systems A Comparative Study of Multi-Technology Corporations in. Technology Management, p. 1–112, 2000.
  • [15] GRANSTRAND, O.; SJÖLANDER, S. The Acquisitions of Technology and Small Firms by Large Firms. Journal of Economic Behavior and Organization, v. 13, p. 367–386, 1990.
  • [16] GRIGORIOU, K.; ROTHAERMEL, F. T. Structural Microfoundations of Innovation: The Role of Relational Stars. Journal of Management, v. 40, n. 2, p. 586–615, 2014.
  • [17] HAGEDOORN, J.; DUYSTERS, G. The Effect of Mergers and Acquisitions on the Technological Performance of Companies in a High-tech Environment. Technology Analysis & Strategic Management, v. 14, n. 1, p. 67–85, 2002a.
  • [18] HAGEDOORN, J.; DUYSTERS, G. External sources of innovative capabilities: The preference for strategic alliances or mergers and acquisitions. Journal of Management Studies, v. 39, n. 2, p. 167–188, 2002b.
  • [19] HALL, B. H.; JAFFE, A. B.; TRAJTENBERG, M. THE NBER PATENT CITATIONS DATA FILE: LESSONS, INSIGHTS AND METHODOLOGICAL TOOLSNo Title: Working paper 8498. [s.l: s.n.].
  • [20] HALL, B. H.; JAFFE, A.; TRAJTENBERG, M. No Title. v. 36, n. 1, p. 16–38, 2013.
  • [21] HOHBERGER, J. Does it pay to stand on the shoulders of giants? An analysis of the inventions of star inventors in the biotechnology sector. Research Policy, v. 45, n. 3, p. 682–698, 2016.
  • [22] HOHBERGER, J.; ALMEIDA, P.; PARADA, P. The direction of firm innovation: The contrasting roles of strategic alliances and individual scientific collaborations. Research Policy, v. 44, n. 8, p. 1473–1487, 2015.
  • [23] MARTIN, P.; NIGHTINGALE, P.; KRAFT, A. Living with “ Dinosaurs ”: Genomics , and the industrial dynamics of the pharmaceutical industry. Science, n. 3, p. 0–24, 2008.
  • [24] NIGHTINGALE, P. Economies of scale in experimentation: knowledge and technology in pharmaceutical R&D. Industrial & Corporate Change, v. 9, n. 2, p. 315, 2000.
  • [25] NORBÄCK, P.; PERSSON, L. Born to be global and the globalization process. 2013.
  • [26] OETTL, A. Reconceptualizing stars: Scientist helpfulness and peer performance. Management Science, v. 58, n. 6, p. 1122–1140, 2012.
  • [27] POWELL, W. W. et al. the Life Sciences Network Dynamics and Field Evolution : The Growth of Interorganizational Collaboration in the Life Sciences 1. American Journal of sociology, v. 110, n. 4, p. 1132–1205, 2013.
  • [28] POWELL W.W. KOPUT, K. W. S.-D. L. Collaboraation and the locus of innovation: networks of learning in biotechnology. Adminisstrative Science Quarterly, v. 41, n. 1, p. 116–145, 1996.
  • [29] SCHWEIZER, L. Organizational integration of acquired biotechnology companies into pharmaceutical companies: The need for a hybrid approach. Academy of Management Journal, v. 48, n. 6, p. 1051–1074, 2005.
  • [30] XIAO, J. The effects of acquisition on the growth of new technology- based firms : Do different types of acquirers matter ? Small Business Economics, p. 487–504, 2015.
  • [31] ZUCKER, L. G.; DARBY, M. R. Present at the biotechnological revolution: transformation of technological identity for a large incumbent pharmaceutical firm. Research Policy, v. 26, n. 4–5, p. 429–446, 1997.
  • [32] ZUCKER, L. G.; DARBY, M. R. Star Scientists, Innovation and Regional and National Immigration. Entrepreneurship and Openness Entrepreneurship and Openness Theory and Evidence, 2009.
  • [33] ZUCKER, L. G.; DARBY, M. R.; ARMSTRONG, J. S. COMMERCIALIZING KNOWLEDGE: UNIVERSITY SCIENCE, KNOWLEDGE CAPTURE, AND FIRM PERFORMANCE IN BIOTECHNOLOGY. NBER Working Paper Series, n. Working Paper 8499, 2001.
  • [34] ZUCKER, L. G.; DARBY, M. R. Star Scientists, Innovation and Regional and National Immigration. Entrepreneurship and Openness Entrepreneurship and Openness Theory and Evidence, 2009.
Como citar:

Matos, Murilo Montanari de; "Interaction between Big-Pharma’s and Small Enterprises: an Analyses Focused on the Incorporation of Inventors", p. 1280-1300 . In: Anais do IV Encontro Nacional de Economia Industrial e Inovação. São Paulo: Blucher, 2019.
ISSN 2357-7592, DOI 10.5151/iv-enei-2019-3.3-091

últimos 30 dias | último ano | desde a publicação


downloads


visualizações


indexações